The Art of Waiting: Making COVID-19 Vaccine Rollouts More Efficient and Cutting Wait Times
The approval of several vaccines against the novel coronavirus is welcome news around the world. Now that there are vaccines proven to work, the struggle has become how to get those shots from labs to human bodies. It’s tough to consume news coverage and not see scenes of long lines of cars or people…
This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.
Free workspace
Turn your Healthcare expertise into content.
Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.
The approval of several vaccines against the novel coronavirus is welcome news around the world. Now that there are vaccines proven to work, the struggle has become how to get those shots from labs to human bodies.
It’s tough to consume news coverage and not see scenes of long lines of cars or people at vaccine rollout sites as counties and states wrestle with the best way to begin protecting people in their communities.
Those lines may be preventable, said Erik Berg, VP of Marketing for NEMO-Q, and it starts with understanding exactly how many people a facility can handle and when they should be asked to join the queue.
“Where we come in is we provide lots of crucial KPIs so these facilities can be as efficient as possible,” Berg said. “Second, when it comes to vaccinating people and getting people tested, 60 seconds adds up to a minute, 60 minutes add up to an hour and so on. We really provide incredibly detailed service times, what you can expect and how long it will take to vaccinate people or test them, so we can get people in and out as quickly and efficiently as possible.”
Providers or government agencies may think their hands are tied by the price of a system like NEMO-Q’s, but the company is working to help stop the spread of COVID-19, as well, and has an affordable and easy-to-use solution for most vaccine providers.
“It is incredibly cost-effective and simple on the end of the healthcare provider,” Berg said. “They’re pretty much hands-off with the process. We know what they need at this point, so we’re looking to be as big of an ally as possible. The budget can stay low. Even some of our more cost-effective, simpler products can make a world of difference when it comes to getting these patients seen as quickly as possible,” Berg said. “We’re willing to work with all these healthcare facilities as best we can.”
With the company’s experience working with healthcare providers even before the pandemic started, solutions required now during the peak of the pandemic can be easily repurposed when the situation improves and things like flu shots, routine appointments, or aches and pains become the primary focus once again. With effective queuing solutions, that could happen even faster than expected.
Follow us on social media for the latest updates in B2B!
Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale
Your experts belong here
Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.
Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.
